138 related articles for article (PubMed ID: 10445048)
1. Novel small molecule nonpeptide aminopeptidase n inhibitors with a cyclic imide skeleton.
Shimazawa R; Takayama H; Fujimoto Y; Komoda M; Dodo K; Yamasaki R; Shirai R; Koiso Y; Miyata K; Kato F; Kato M; Miyachi H; Hashimoto Y
J Enzyme Inhib; 1999; 14(4):259-75. PubMed ID: 10445048
[TBL] [Abstract][Full Text] [Related]
2. Nonpeptide small-molecular inhibitors of dipeptidyl peptidase IV: N-phenylphthalimide analogs.
Shimazawa R; Takayama H; Kato F; Kato M; Hashimoto Y
Bioorg Med Chem Lett; 1999 Feb; 9(4):559-62. PubMed ID: 10098663
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of novel specific aminopeptidase inhibitors with a cyclic imide skeleton].
Takahashi H; Komoda M; Kakuta H; Hashimoto Y
Yakugaku Zasshi; 2000 Oct; 120(10):909-21. PubMed ID: 11082703
[TBL] [Abstract][Full Text] [Related]
4. Novel leucine ureido derivatives as inhibitors of aminopeptidase N (APN).
Ma C; Jin K; Cao J; Zhang L; Li X; Xu W
Bioorg Med Chem; 2013 Apr; 21(7):1621-7. PubMed ID: 23453219
[TBL] [Abstract][Full Text] [Related]
5. Leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry. Part II.
Cao J; Zang J; Kong X; Zhao C; Chen T; Ran Y; Dong H; Xu W; Zhang Y
Bioorg Med Chem; 2019 Mar; 27(6):978-990. PubMed ID: 30737134
[TBL] [Abstract][Full Text] [Related]
6. Aminopeptidase N (APN/CD13) as a target for anti-cancer agent design.
Zhang X; Xu W
Curr Med Chem; 2008; 15(27):2850-65. PubMed ID: 18991640
[TBL] [Abstract][Full Text] [Related]
7. Novel leucine ureido derivatives as aminopeptidase N inhibitors using click chemistry.
Cao J; Ma C; Zang J; Gao S; Gao Q; Kong X; Yan Y; Liang X; Ding Q; Zhao C; Wang B; Xu W; Zhang Y
Bioorg Med Chem; 2018 Jul; 26(12):3145-3157. PubMed ID: 29859750
[TBL] [Abstract][Full Text] [Related]
8. Design of Aminopeptidase N Inhibitors as Anti-cancer Agents.
Amin SA; Adhikari N; Jha T
J Med Chem; 2018 Aug; 61(15):6468-6490. PubMed ID: 29630364
[TBL] [Abstract][Full Text] [Related]
9. Novel potent nonpeptide aminopeptidase N inhibitors with a cyclic imide skeleton.
Miyachi H; Kato M; Kato F; Hashimoto Y
J Med Chem; 1998 Jan; 41(3):263-5. PubMed ID: 9464355
[No Abstract] [Full Text] [Related]
10. Design and synthesis of novel chloramphenicol amine derivatives as potent aminopeptidase N (APN/CD13) inhibitors.
Yang K; Wang Q; Su L; Fang H; Wang X; Gong J; Wang B; Xu W
Bioorg Med Chem; 2009 Jun; 17(11):3810-7. PubMed ID: 19423354
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and preliminary activity evaluation of novel 3-amino-2-hydroxyl-3-phenylpropanoic acid derivatives as aminopeptidase N/CD13 inhibitors.
Zhang X; Zhang L; Zhang J; Feng J; Yuan Y; Fang H; Xu W
J Enzyme Inhib Med Chem; 2013 Jun; 28(3):545-51. PubMed ID: 22380779
[TBL] [Abstract][Full Text] [Related]
12. Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.
Bauvois B; Dauzonne D
Med Res Rev; 2006 Jan; 26(1):88-130. PubMed ID: 16216010
[TBL] [Abstract][Full Text] [Related]
13. Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin.
Shim JS; Kim JH; Cho HY; Yum YN; Kim SH; Park HJ; Shim BS; Choi SH; Kwon HJ
Chem Biol; 2003 Aug; 10(8):695-704. PubMed ID: 12954328
[TBL] [Abstract][Full Text] [Related]
14. Novel aminopeptidase N (APN/CD13) inhibitors derived from 3-phenylalanyl-N'-substituted-2,6-piperidinedione.
Zhang X; Fang H; Zhu H; Wang X; Zhang L; Li M; Li Q; Yuan Y; Xu W
Bioorg Med Chem; 2010 Aug; 18(16):5981-7. PubMed ID: 20637634
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in the development of MMPIs and APNIs based on the pyrrolidine platforms.
Li X; Li J
Mini Rev Med Chem; 2010 Aug; 10(9):794-805. PubMed ID: 20482497
[TBL] [Abstract][Full Text] [Related]
16. Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2,4(1H,3H)-quinazolinedione skeleton.
Kakuta H; Tanatani A; Nagasawa K; Hashimoto Y
Chem Pharm Bull (Tokyo); 2003 Nov; 51(11):1273-82. PubMed ID: 14600372
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of a novel series of L-isoserine derivatives as aminopeptidase N inhibitors.
Yang K; Fen J; Fang H; Zhang L; Gong J; Xu W
J Enzyme Inhib Med Chem; 2012 Apr; 27(2):302-10. PubMed ID: 21770859
[TBL] [Abstract][Full Text] [Related]
18. Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.
Cui SX; Qu XJ; Gao ZH; Zhang YS; Zhang XF; Zhao CR; Xu WF; Li QB; Han JX
Cancer Lett; 2010 Jun; 292(2):153-62. PubMed ID: 20042271
[TBL] [Abstract][Full Text] [Related]
19. Recent advance in aminopeptidase N (APN/CD13) inhibitor research.
Zhang X; Fang H; Zhang J; Yuan Y; Xu W
Curr Med Chem; 2011; 18(32):5011-21. PubMed ID: 22050749
[TBL] [Abstract][Full Text] [Related]
20. Aminopeptidase N (APN)/CD13 inhibitor, Ubenimex, enhances radiation sensitivity in human cervical cancer.
Tsukamoto H; Shibata K; Kajiyama H; Terauchi M; Nawa A; Kikkawa F
BMC Cancer; 2008 Mar; 8():74. PubMed ID: 18366676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
